Maria Pia Adorni - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maria Pia Adorni

Showing results (11-20 of 70) with videos related to

Pageof 7

Sort By:

International Journal of Food Sciences and Nutrition|November 29, 2023

<i>In vitro</i> evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefenceBianca Papotti, Mattia Dessena, Maria Pia Adorni, et al.

Reviews in Endocrine & Metabolic Disorders|February 22, 2021

Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failureBaris Gencer, Marco Bonomi, Maria Pia Adorni, et al.

Rheumatic Diseases Clinics of North America|November 24, 2022

Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic DiseasesNicoletta Ronda, Francesca Zimetti, Maria Pia Adorni, et al.

Current Pharmaceutical Design|October 2, 2025

Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's DiseaseMartina Ugolotti, Bianca Papotti, Alessandro Trentini, et al.

Oxidative Medicine and Cellular Longevity|January 28, 2021

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative ReviewFrancesca Zimetti, Maria Pia Adorni, Judit Marsillach, et al.

Biochemistry|October 21, 2009

Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1Elda Favari, Laura Calabresi, Maria Pia Adorni, et al.

Pharmacological Research|January 14, 2020

Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemiaMassimiliano Ruscica, Francesca Zimetti, Maria Pia Adorni, et al.

FEBS Letters|November 18, 2005

Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophagesElda Favari, Francesca Zimetti, Anna E Bortnick, et al.

International Journal of Molecular Sciences|April 13, 2024

Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell LineIlaria Rossi, Giorgia Marodin, Maria Giovanna Lupo, et al.

Therapeutics and Clinical Risk Management|December 23, 2017

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9Maria Pia Adorni, Nicola Ferri, Silvia Marchianò, et al.

Pageof 7

Search research articles

Showing results (11-20 of 70) with videos related to

Sort By:

Pageof 7

International Journal of Food Sciences and Nutrition|November 29, 2023

<i>In vitro</i> evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefenceBianca Papotti, Mattia Dessena, Maria Pia Adorni, et al.

Reviews in Endocrine & Metabolic Disorders|February 22, 2021

Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failureBaris Gencer, Marco Bonomi, Maria Pia Adorni, et al.

Rheumatic Diseases Clinics of North America|November 24, 2022

Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic DiseasesNicoletta Ronda, Francesca Zimetti, Maria Pia Adorni, et al.

Current Pharmaceutical Design|October 2, 2025

Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's DiseaseMartina Ugolotti, Bianca Papotti, Alessandro Trentini, et al.

Oxidative Medicine and Cellular Longevity|January 28, 2021

Biochemistry|October 21, 2009

Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1Elda Favari, Laura Calabresi, Maria Pia Adorni, et al.

Pharmacological Research|January 14, 2020

Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemiaMassimiliano Ruscica, Francesca Zimetti, Maria Pia Adorni, et al.

FEBS Letters|November 18, 2005

Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophagesElda Favari, Francesca Zimetti, Anna E Bortnick, et al.

International Journal of Molecular Sciences|April 13, 2024

Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell LineIlaria Rossi, Giorgia Marodin, Maria Giovanna Lupo, et al.

Therapeutics and Clinical Risk Management|December 23, 2017

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9Maria Pia Adorni, Nicola Ferri, Silvia Marchianò, et al.

Pageof 7